Prostate cancer is the second most common cancer in American men. While the disease is prevalent across the country, the screening guidelines are not. Prostate cancer screenings have always been somewhat controversial because the tests often alert physicians to the presence of cancer, but there is no precise way to determine, definitively, whether the cancer […]
Thanks to advancements in research and treatment methods, men diagnosed with prostate cancer have more options and resources available to them than ever before. Whether you or a loved one has been newly diagnosed with prostate cancer, talking to your doctor to learn more about the disease and treatments that are right for you is […]
Are you a male who has never been diagnosed with prostate cancer and: Between the ages of 50 and 80 years old, Between the ages of 40 and 50 years old with a first-degree relative under the age of 70 diagnosed with prostate cancer, or African American and at least 40 years old? Answering yes […]
As the COVID-19 pandemic continues, many cancer patients are having to make the difficult decision to continue with their current cancer regimen or delay treatments. Cancer patients and physicians must carefully weigh the potential benefit of routine cancer care versus the risk of COVID-19. To help ease these decisions, several peer-reviewed, non-profit cancer care organizations […]
Watch Ray talk about his experience receiving CyberKnife treatment for his prostate cancer at Reno CyberKnife. For more information on how prostate cancer is treated by CyberKnife technology, please visit RenoCyberKnife.com today.
When deciding which treatment option is best for their prostate cancer, men take numerous factors into consideration. While their physician’s recommendation does play an important role in the treatment decision, in the end, most men make the choice that is best for them. That choice is often based on treatment outcomes and side effects, and […]
One in eight. That is how many men will be diagnosed with prostate cancer during his lifetime. According to the American Cancer Society, prostate cancer is the most common cancer in American men and almost 2,090 new cases of prostate cancer will be diagnosed in Nevada this year. There are several risk factors associated with […]
Accuray Incorporated, developer and manufacturer of the CyberKnife® System, announced that published data from two multicenter studies using differing protocols provide consistent results and reinforce the use of the CyberKnife system for the effective management of low-and intermediate-risk prostate cancer. The studies are the largest conducted to date evaluating stereotactic body radiation therapy (SBRT) in […]
Check out our latest radio spot, running on KRLT 93.9 FM and KOWL 1490 AM, that discusses the stats of veterans and prostate cancer, treating prostate cancer with CyberKnife technology, and promotes the free “Veterans & Prostate Cancer: What You to Know” educational community event.